Thirty patients with moderate dyslipidemia and metabolic syndrome ( according to the Third Report of the National Cholesterol Education Program Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ) were included in an @-week randomized , double-blind crossover study and took either placebo or a nutraceutical combination that contained red yeast rice extract , berberine , policosanol , astaxanthin , coenzyme Q@ , and folic acid ( Armolipid Plus ) .